{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-01-07T12:27:32.369036+00:00",
  "news": [
    {
      "title": "AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5",
      "summary": "<ol><li><a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxPUUx5bW1JMG82U3I3c3JNMVFfNWVFcklFUUstVWNiQS0yWUdpLXBSTEE2TnlxRlRvOVhJUS1mUTdqeFEwZ3duNXZlV0dyWTNSVHhJeklDczI4aVpybkFVSXluaDA0b3g1WHdEZTJkNzVpbEw5XzNXbGlyRHd2QmV5NUNSTWVPdVVZdjZ0VUR1bHB2UkdLMDVKZkxwS3NWSkY4bUUwQlRWdG16UUFUcV8xWjdlWWhsQ2NZWXV0MjJrNA?oc=5\" target=\"_blank\">AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font></li><li><a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxORllWRVExTGxMODFRMHdDTjF3d093Y2RrM1NqNERDdkpHc2I4bXdDREowaFpxeWhYZERvcG5wdWtRMEl2YjZpWXZUV0VEWVRDQmhvR2x6eEt2ZklpLUl2eUpQN2VQZFUyNFVXSEJDeEU0Z3JlYUVHSVZoZUNhQXNhLWZVeUhSZFZBQzVZdEdycGtaeGdydVAwbmJjN1J3QjM3MUN4UUdCaXVYT0ZRWmc?oc=5\" target=\"_blank\">Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font></li><li><a href=\"https://news.google.com/rss/articles/CBMigAFBVV95cUxOa044Y293MWYzbUxtYmNwNkpnM1NKQUJYcTVBZjBYb01vZnJRdDdiNXhvR1dkWDhmTERoMlFjVUYzUzgwbzBRcUtUTVhBbFp1dFJLRjFSQ3N3WW5RUllCYTY4aWlIb2NvODB2RHgwVkVlLV9zbWhXRU0xS3B1U2V5Ng?oc=5\" target=\"_blank\">Amgen buys a novel leukaemia target | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQajF5MUNsd0IyX1V1RTlGZE10UDhCQWNRWkZOTXRlcHZMa1Z3ODdqNkRidW5RLURnWFl4QWpkbkI2RnllLV9uVEk5bTVWNUdjSE1hQWJkU0NyM2NlVDlmRkt5aE9hbGtHSE40MVFudzdTb2QtdjIwWW9pMDhPbVhKVjF1T2ZOcGw0RVgzT2lVTDY0RXdYNnFzWjdKRkJZdEg5eXc?oc=5\" target=\"_blank\">Amgen buys protein-degrading startup Dark Blue for up to $840M</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font></li><li><a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxQZi10dWpNLTdLQWNQVEY4Zy04MmRET09KNzBlaXZ3RkUwNllPX0o2NFpEWEtZNGk4Y3FFT3VKaEFSblA5SklHSGNGbE5lZmV2MlJodU9oYnk5NVdNWGR5alBfWFZsMlpRd3ZXR0JPeElWMENnSnZkRDFwcUNXcjN3d2pyRTQ?oc=5\" target=\"_blank\">Amgen to acquire Oxford spinout Dark Blue, tucking in a preclinical cancer drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font></li><li><a href=\"https://news.google.com/rss/articles/CBMicEFVX3lxTE9oMzhkWTdYVlNSb0hOWjVaWHdFN05VOEUyMlJpQmdpTmdaaTJHR2ZMN0xCUXBFeERWNGd4cUwyUW5GWTVwQ0VuQ1o0NmdXdFVaeWxVWDdxN2c1aGtDNVEzVzRTUEwwclF1ZC1qZ0JnU2I?oc=5\" target=\"_blank\">Amgen swoops on UK cancer biotech in deal worth up to $840mn</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Financial Times</font></li><li><a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxNQkMzTWdVWGVhSjFfZnJTTUo0cmo3UXg0SGdjNnB3b0xBZmtjdUE0Z2lwMnBJcUZTWUFLMzExY2JfZm8tUW5uTUc5eDh4dlNwdC00YUtPd3JCOWJvUl9sY2VJUURmclZRYS1lUFRqbzBOOGVKU0pZLU1xb1M1RXRKNVdrTEM3dzdidHNNZnFveW52NTdYcUlrM1FNQ29aODdSbmo3QzRHeWFXV3dqTzJtZWJkRVZUQTRndkV4U2tZU0dUQzRnVm9V?oc=5\" target=\"_blank\">M&amp;A News: Amgen Stock (AMGN) Brightens after $840M Capture of British Cancer-Fighting Biotech Dark Blue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font></li></ol>",
      "published": "2026-01-06T14:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Cancer biotech Disco lines up Amgen as first pharma partner - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjdCQ2lFQlFfU2lhV19RNXIzSmtjZU9KWDZGVW9rSUp5cVpuN05nRUsycTVYd0piZ29neDIxYVh3aEFzU190T0tHMUJCb2Ywc1prV25yWlhINzV1THR6cE1aWHYwanc3UXlCX2ZvLTQ4YkRwSVRydVljS1UxMGpRbFBLNFFEV1haZG0w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNbjdCQ2lFQlFfU2lhV19RNXIzSmtjZU9KWDZGVW9rSUp5cVpuN05nRUsycTVYd0piZ29neDIxYVh3aEFzU190T0tHMUJCb2Ywc1prV25yWlhINzV1THR6cE1aWHYwanc3UXlCX2ZvLTQ4YkRwSVRydVljS1UxMGpRbFBLNFFEV1haZG0w?oc=5\" target=\"_blank\">Cancer biotech Disco lines up Amgen as first pharma partner</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2026-01-07T10:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "AbbVie Challenges Amgen With $100M Upfront for Trispecific Lung Cancer Drug - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMUtNeXAxZWhJV1Y1S3N3cWR3OC1CS0YxSF9yNXZ6TThtOUdzN1dlUS1CaHhfaWQxRE1CUVVaWXFGVW4yR1lxdGtGRkNpZVptdGhuNTVrUHFDRFZ5cTNIT2w1c0RvM1c2Qm5mbnMyYWdCNHhEVWpPZWNxV3ZvQ1lkNWYtOWVBMWZKcm1ocFVzVkxMQThRUW5WM0NJR0VpbGdFeGxGOWhHSHQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPMUtNeXAxZWhJV1Y1S3N3cWR3OC1CS0YxSF9yNXZ6TThtOUdzN1dlUS1CaHhfaWQxRE1CUVVaWXFGVW4yR1lxdGtGRkNpZVptdGhuNTVrUHFDRFZ5cTNIT2w1c0RvM1c2Qm5mbnMyYWdCNHhEVWpPZWNxV3ZvQ1lkNWYtOWVBMWZKcm1ocFVzVkxMQThRUW5WM0NJR0VpbGdFeGxGOWhHSHQ?oc=5\" target=\"_blank\">AbbVie Challenges Amgen With $100M Upfront for Trispecific Lung Cancer Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2026-01-05T13:11:31+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1GQnRmdDBPN1JsSi13ak1Rcm45a1VtZlU0YmcwMGh4QTFQR3gwWGVhOTlDTEtYTmU2RS1ZUHhvcUZtU2ZPenp5Y1YtNkZpUUJBRVdjUnZEcXRXM2Y0OFlsX0t5VGtYSVdxeWIwUUlqTm9rRzNXNnJuQXRzRVBNQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMifkFVX3lxTE1GQnRmdDBPN1JsSi13ak1Rcm45a1VtZlU0YmcwMGh4QTFQR3gwWGVhOTlDTEtYTmU2RS1ZUHhvcUZtU2ZPenp5Y1YtNkZpUUJBRVdjUnZEcXRXM2Y0OFlsX0t5VGtYSVdxeWIwUUlqTm9rRzNXNnJuQXRzRVBNQQ?oc=5\" target=\"_blank\">Beat the Market the Zacks Way: LATAM, General Motors, Amgen in Focus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-05T12:52:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen buys Dark Blue Therapeutics in $840m oncology deal - Pharmaceutical Technology",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxONGkwYmdDcHRjUnVDVlQ0eXpRWlV6eVczU29UekZpcndSNC1yUDh6TUJVLTJFS2tVaXFfbUljSFFfR2g3ZXJxazFuRUlWUXpidFg2VDlsak5HYkEwY3FiVkFTYUw3OVVRZEhCMjBBZFpSUXBHS3R3cGZJUEI1Vk5la2JlQWhHN0kzbS1BNUM0SXhYZHJLTnRBdzFaX3FKaVVNeE9rN1FwZjRYMi03RGVOejgzZDlETGNDYTdZbA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxONGkwYmdDcHRjUnVDVlQ0eXpRWlV6eVczU29UekZpcndSNC1yUDh6TUJVLTJFS2tVaXFfbUljSFFfR2g3ZXJxazFuRUlWUXpidFg2VDlsak5HYkEwY3FiVkFTYUw3OVVRZEhCMjBBZFpSUXBHS3R3cGZJUEI1Vk5la2JlQWhHN0kzbS1BNUM0SXhYZHJLTnRBdzFaX3FKaVVNeE9rN1FwZjRYMi03RGVOejgzZDlETGNDYTdZbA?oc=5\" target=\"_blank\">Amgen buys Dark Blue Therapeutics in $840m oncology deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaceutical Technology</font>",
      "published": "2026-01-07T12:05:13+00:00",
      "source": "Pharmaceutical Technology"
    },
    {
      "title": "Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal - European Biotechnology Magazine",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRG9hRE9LVWU3OHpydk4ybWZDdzBTazF6YzFuenFvdnhMcXVkWWljNmVyQmlpaTQ5X0pvM082RFNnWk9jdWJvVjdyRTB0aVlvX1ZKaDktSldWUGUzSWdGRVhmd2owUmZKdHdqVEFqdXVZTEJmWkd2dE1NdWhuZGdyZ1Y0OU5LVFF0TlhkQTY4b282OVpzRkh3VWVXVnUxakUyUGItSmZoaXNuYzdlOUx5bVNsenZtM1RNOVVWdUVXSFkwQkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNRG9hRE9LVWU3OHpydk4ybWZDdzBTazF6YzFuenFvdnhMcXVkWWljNmVyQmlpaTQ5X0pvM082RFNnWk9jdWJvVjdyRTB0aVlvX1ZKaDktSldWUGUzSWdGRVhmd2owUmZKdHdqVEFqdXVZTEJmWkd2dE1NdWhuZGdyZ1Y0OU5LVFF0TlhkQTY4b282OVpzRkh3VWVXVnUxakUyUGItSmZoaXNuYzdlOUx5bVNsenZtM1RNOVVWdUVXSFkwQkU?oc=5\" target=\"_blank\">Amgen selects German Disco Pharma to collaborate in multi-million-dollar deal</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">European Biotechnology Magazine</font>",
      "published": "2026-01-07T11:55:14+00:00",
      "source": "European Biotechnology Magazine"
    },
    {
      "title": "Amgen inks $840m takeover of UK's Dark Blue Therapeutics - Pharmaphorum",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb2pxbHltVkJOVWNHYUxqdW9STXZxdHZNYlRTeFZ4Z1ZpdGVNczlQS21kaktncU5uSHMyR1VXWTJKLVlDUFpVejhPcXdJUVhrU1RBVi1tVE9WbUpsWWt6S0hGTGJ6YmY1M3dlUmRyaTNYcjUxNDcxUzE5VEJLVmRhOVEwcS1UT2tv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNb2pxbHltVkJOVWNHYUxqdW9STXZxdHZNYlRTeFZ4Z1ZpdGVNczlQS21kaktncU5uSHMyR1VXWTJKLVlDUFpVejhPcXdJUVhrU1RBVi1tVE9WbUpsWWt6S0hGTGJ6YmY1M3dlUmRyaTNYcjUxNDcxUzE5VEJLVmRhOVEwcS1UT2tv?oc=5\" target=\"_blank\">Amgen inks $840m takeover of UK's Dark Blue Therapeutics</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharmaphorum</font>",
      "published": "2026-01-06T15:40:29+00:00",
      "source": "Pharmaphorum"
    },
    {
      "title": "Amgen taps DISCO’s surfaceome tech for $618M to develop onco therapies - FirstWord",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1Tandha1RVQm0tX0V0b0JhTFRHbmdubmRrTEF3R2tDUlliX1hKTmNqc3BlN1ZJWkdLOTBBa1NUUGQ2dUJXV19sWEFLNXpzM2ZSOXRJ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1Tandha1RVQm0tX0V0b0JhTFRHbmdubmRrTEF3R2tDUlliX1hKTmNqc3BlN1ZJWkdLOTBBa1NUUGQ2dUJXV19sWEFLNXpzM2ZSOXRJ?oc=5\" target=\"_blank\">Amgen taps DISCO’s surfaceome tech for $618M to develop onco therapies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord</font>",
      "published": "2026-01-07T08:19:39+00:00",
      "source": "FirstWord"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-01-06",
      "close": 330.1700134277344
    },
    "history": [
      {
        "date": "2025-12-26",
        "close": 332.92999267578125
      },
      {
        "date": "2025-12-29",
        "close": 329.6300048828125
      },
      {
        "date": "2025-12-30",
        "close": 328.69000244140625
      },
      {
        "date": "2025-12-31",
        "close": 327.30999755859375
      },
      {
        "date": "2026-01-02",
        "close": 327.6400146484375
      },
      {
        "date": "2026-01-05",
        "close": 320.7200012207031
      },
      {
        "date": "2026-01-06",
        "close": 330.1700134277344
      }
    ],
    "name": "Amgen Inc."
  }
}